Newest
-
SINOMA International Hosts 3rd SINOMA Cement Green & Intelligent Summit, Charting Course for Sustainable Industry
-
E-TIK 2025 strategic goal: global branch layout, shouldering global social responsibility, and moving towards new heights!
-
Tech Breakthrough: Haokun Cheng Leads Google Spanner Project to New Heights
-
A solemn statement on "Leighton International" impersonating the Group to engage in illegal activities
Business
-
HONOR Introduces the Ultra-thin HONOR Pad V9 at MWC 2025
BARCELONA,Spain,March 3,2025-- HONOR today announced the HONOR ALPHA PLAN,a new corporate strategy to transform HONOR from a smartphone maker to a global leading AI device ecosystem company. Funded b
03-05
Details -
TCL Introduces Six New Models in the TCL 60 Series, Enhancing Connectivity and User Engagement by Diversifying Portfolio
BARCELONA,Spain,March 3,2025-- TCL,a pioneer in display across feature-rich smartphones,tablets,and connected devices,today expanded its TCL 60 series with the introduction of six additional smartphon
03-05
Details -
ESR Unveils Upgraded Digital Presence Reflecting Its Focus on Innovation and Technology
Transformation fromESR Gear to ESR Tech further advances the mission of "Tech Made Easier",enhancing everyday tech experiences with innovative solutions
03-05
Details -
Paeonia Industries Announces Acquisition of the Savant Group of companies
MIDLAND,Mich.,March 3,2025-- Paeonia Industries,a premier global firm with deep roots in analytical equipment manufacturing for energy testing,as well as the distribution of scientific testing instrum
03-05
Details -
CStone Announces First Patient Dosed in Global Multicenter Phase I Clinical Trial of CS2009, a PD-1/VEGF/CTLA-4 Trispecific Antibody
SUZHOU,China,March 4,2025--CStone Pharmaceuticals ("CStone",HKEX: 2616),an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies,today
03-05
Details -
Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®
STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
03-05
Details -
Tokyo, Bangkok Aligned to Fight Disasters and Other Common Challenges
TOKYO,March 4,2025-- In a display of global city strategy,the governors of Tokyo and Bangkok have lined up to tackle climate-linked natural disasters,an aging and shrinking population,and other challe
03-05
Details -
Digital Garden Tokyo to Feature Unprecedented Speaker Lineup and Over 80 Companies Represented by C-Suite Delegations at Japan's First Global-Scale Digital Infrastructure Summit
TOKYO,March 4,2025-- With just two weeks until the highly anticipated Digital Garden Tokyo,excitement is building for Japan\'s inaugural global-scale digital infrastructure summit. Taking place on Mar
03-05
Details -
AIFIAN Releases Asia-Pacific Investment Report: Baijiu Emerges as a Strong Investment Asset
NEW YORK,March 4,2025-- AIFIAN has released its 2024 Asia-Pacific investment report,highlighting key trends in liquor investment across the region. The findings reveal that Baijiu has emerged as the
03-05
Details -
Turnitin launches Turnitin Clarity, bringing transparency and integrity insights to education
New offering delivers a composition workspace for students with educator-guided AI assistance,assignment-to-grading workflows and integrity insights - all in one place
03-05
Details